U.S. intelligence says Putin still aims to control all of Ukraine
US intelligence assessments indicate that Russian President Vladimir Putin continues to seek full control of Ukraine and to expand Russia’s influenc...
BioNTech forecasts a revenue decline for 2025, expecting between 1.7 billion and 2.2 billion euros, down from 2.75 billion euros last year. This drop is due to Pfizer write-downs and stable vaccination rates. BioNTech also plans significant job cuts and new hires.
BioNTech, the German biotech company behind the COVID-19 vaccine, has warned of a significant decline in 2025 revenues, expecting them to range between 1.7 billion euros and 2.2 billion euros. This forecast is notably below the 2.75 billion euros reported last year and lower than analyst expectations of around 2.5 billion euros for 2025.
The company attributed the expected revenue drop to stable vaccination rates and anticipated inventory write-downs at its collaboration partner Pfizer, which will negatively impact sales. Additionally, BioNTech revealed plans to reduce its workforce by 950 to 1,350 full-time positions by 2027, impacting its manufacturing and research operations in Europe and North America.
However, BioNTech also intends to add between 800 and 1,200 new roles, especially in its large-scale mRNA immunotherapy manufacturing facility in Mainz and through its acquisition of Biotheus. Despite these changes, the company expects its overall headcount to remain relatively stable in the next three years. Following the announcement, BioNTech's stock fell by 4.3%, reflecting investor concerns.
Ukraine has welcomed the European Union’s decision to provide €90 billion in support over the next two years, calling it a vital lifeline even as the bloc failed to reach agreement on using frozen Russian assets to finance the aid.
European Union foreign policy chief Kaja Kallas has warned that attempts to reach a peace agreement in Ukraine are being undermined by Russia’s continued refusal to engage meaningfully in negotiations.
A rare pair of bright-green Nike “Grinch” sneakers worn and signed by the late NBA legend Kobe Bryant have gone on public display in Beverly Hills, ahead of an auction that could set a new record for sports memorabilia.
Chinese Foreign Minister Wang Yi has held a phone conversation with his Venezuelan counterpart Yvan Gil at the latter’s request.
Petroleum products are being transported by rail from Azerbaijan to Armenia for the first time in decades. The move is hailed as a tangible breakthrough in efforts to normalise relations between the long-time rivals.
Warner Bros Discovery’s board rejected Paramount Skydance’s $108.4 billion hostile bid on Wednesday (17 December), citing insufficient financing guarantees.
Ford Motor Company said on Monday it will take a $19.5 billion writedown and scrap several electric vehicle (EV) models, marking a major retreat from its battery-powered ambitions amid declining EV demand and changes under the Trump administration.
Iran has rolled out changes to how fuel is priced at the pump. The move is aimed at managing demand without triggering public anger.
U.S. stock markets closed lower at the end of the week, as investors continued to rotate out of technology shares, putting pressure on major indices.
The U.S. Federal Reserve’s Federal Open Market Committee (FOMC) cut its benchmark interest rate by 25 basis points to a range of 3.50% to 3.75% following its two-day policy meeting, according to an official statement issued on Wednesday, 10 December.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment